Press Releases

Date	Title	PDF Version
May 08, 2018	Alexion to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
Apr 26, 2018	Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study
Apr 12, 2018	Alexion to Report First Quarter 2018 Results on Thursday, April 26, 2018
Apr 11, 2018	Alexion to Acquire Wilson Therapeutics
Mar 15, 2018	Alexion Announces Positive Top-Line Results Showing Successful Phase 3 Clinical Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Mar 07, 2018	Alexion to Present at the Cowen and Company 38th Annual Health Care Conference
Feb 27, 2018	The Manton Center at Boston Children's Hospital and Alexion Pharmaceuticals Partner in Artificial Intelligence Approaches to Rare Disease Diagnosis
Feb 08, 2018	Alexion Reports Fourth Quarter and Full Year 2017 Results and Provides Financial Guidance for 2018
Feb 06, 2018	Data Presented at WORLDSymposium™ 2018 Show Survival to 3 Years of Age and Improvements in Liver Function in Infants with Lysosomal Acid Lipase Deficiency Treated with Kanuma® (sebelipase alfa)
Feb 05, 2018	Alexion Appoints Judith A. Reinsdorf, J.D., to its Board of Directors

Search